3 minute read
Mar. 14, 2023
YCT529: a Potential Non-Hormonal Male Contraceptive
YourChoice/UMN RAR-α antagonist
oral, non-hormonal male contraceptive oral efficacy (99%) in preclinical model SBDD from retinoic acid YCT529 YourChoice Therapeutics, Berkeley, CA / UMN (Georg Lab), MN